Valuation Becton, Dickinson and Company London S.E.

Stocks

Delayed London S.E. 09:30:01 2026-08-14 EDT			5-day change	1st Jan Change
182.12 ^USD	+1.80%		+3.08%	-6.91%

08-13	Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says	MT
08-13	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: September	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	70,597	63,550	75,002	69,688	53,648	49,956	-	-
Change	-	-9.98%	18.02%	-7.08%	-23.02%	-6.88%	-	-
Enterprise Value (EV) ¹	85,924	78,609	89,465	88,081	72,188	65,841	63,907	62,141
Change	-	-8.51%	13.81%	-1.55%	-18.04%	-8.79%	-2.94%	-2.76%
P/E	35.9x	37.9x	52.3x	40.7x	32.2x	35.3x	19.7x	16.3x
PBR	2.95x	3.21x	3.71x	2.69x	2.1x	1.95x	1.84x	1.74x
PEG	-	-2.7x	-3.3x	2x	-17.36x	-3.3x	0.2x	0.8x
Capitalization / Revenue	3.49x	3.37x	3.87x	3.44x	2.46x	2.59x	2.53x	2.43x
EV / Revenue	4.24x	4.17x	4.62x	4.35x	3.31x	3.41x	3.24x	3.03x
EV / EBITDA	14.7x	15.2x	13.1x	12.4x	12x	11.7x	11.1x	10.2x
EV / EBIT	17.3x	18x	19.6x	18.3x	13.2x	13.6x	13x	12x
EV / FCF	25.2x	52.5x	42.3x	28.2x	27x	20.8x	24x	22.2x
FCF Yield	3.98%	1.91%	2.37%	3.54%	3.7%	4.8%	4.16%	4.51%
Dividend per Share ²	3.32	3.48	3.64	3.8	4.16	3.924	3.991	3.993
Rate of return	1.35%	1.56%	1.41%	1.58%	2.22%	2.14%	2.18%	2.18%
EPS ²	6.85	5.88	4.94	5.93	5.82	5.189	9.309	11.28
Distribution rate	48.5%	59.2%	73.7%	64.1%	71.5%	75.6%	42.9%	35.4%
Net sales ¹	20,248	18,870	19,372	20,245	21,840	19,291	19,733	20,530
EBITDA ¹	5,838	5,160	6,846	7,099	6,028	5,628	5,759	6,087
EBIT ¹	4,971	4,362	4,558	4,813	5,468	4,832	4,927	5,175
Net income ¹	2,002	1,689	1,424	1,726	1,678	1,437	2,340	2,714
Net Debt ¹	15,327	15,059	14,463	18,393	18,540	15,885	13,952	12,185
Reference price ²	245.82	222.83	258.53	241.10	187.17	183.40	183.40	183.40
Nbr of stocks (in thousands)	287,190	285,195	290,109	289,042	286,627	272,387	-	-
Announcement Date	11/4/21	11/10/22	11/9/23	11/7/24	11/6/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ABBOTT LABORATORIES	31.91x	4.3x	16.65x	2.31%	193B
MEDTRONIC PLC	20.68x	3.58x	12.58x	3.26%	117B
CENCORA, INC.	17.18x	0.2x	12.43x	0.76%	59.89B
HOYA CORPORATION	32.51x	8.12x	20.71x	1.22%	56.01B
BECTON, DICKINSON AND COMPANY	35.34x	3.41x	11.7x	2.14%	49.96B
DEXCOM, INC.	35.98x	6.33x	19.87x	-.--%	33.87B
MEDLINE INC.	46.51x	1.32x	12.08x	0.16%	31.36B
TERUMO CORPORATION	20.88x	3.19x	11.7x	1.4%	24.77B
WEST PHARMACEUTICAL SERVICES, INC.	40.75x	7.14x	25.62x	0.26%	24.59B
Average	31.30x	4.18x	15.93x	1.28%	65.53B
Weighted average by Cap.	29.45x	4.06x	15.49x	1.85%